Guggenheim Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Guggenheim Capital’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$266K	Buy	+956	New	+$275K	﹤0.01%	1425
2025 Q4	–	Sell	-824	Closed	-$231K	–	1754
2025 Q3	$231K	Sell	824 -157	-16%	-$42.7K	﹤0.01%	1478
2025 Q2	$237K	Sell	981 -29	-3%	-$6.86K	﹤0.01%	1459
2025 Q1	$246K	Sell	1,010 -8	-0.8%	-$2.41K	﹤0.01%	1476
2024 Q4	$334K	Sell	1,018 -612	-38%	-$208K	﹤0.01%	1410
2024 Q3	$545K	Sell	1,630 -1,067	-40%	-$339K	﹤0.01%	1369
2024 Q2	$737K	Sell	2,697 -59	-2%	-$17.2K	0.01%	1262
2024 Q1	$953K	Sell	2,756 -473	-15%	-$156K	0.01%	1209
2023 Q4	$1.04M	Buy	3,229 +1,443	+81%	+$452K	0.01%	1144
2023 Q3	$640K	Sell	1,786 -20	-1%	-$7.72K	0.01%	1309
2023 Q2	$685K	Sell	1,806 -128	-7%	-$52.1K	0.01%	1328
2023 Q1	$926K	Buy	1,934 +580	+43%	+$272K	0.01%	1221
2022 Q4	$569K	Sell	1,354 -238	-15%	-$96.1K	0.01%	1421
2022 Q3	$664K	Buy	1,592 +250	+19%	+$125K	0.01%	1354
2022 Q2	$664K	Sell	1,342 -3,695	-73%	-$1.92M	0.01%	1432
2022 Q1	$2.84M	Sell	5,037 -1,544	-23%	-$931K	0.02%	871
2021 Q4	$4.97M	Sell	6,581 -6,459	-50%	-$4.83M	0.03%	688
2021 Q3	$9.73M	Sell	13,040 -3,336	-20%	-$2.5M	0.06%	393
2021 Q2	$10.6M	Buy	16,376 +5,125	+46%	+$3.12M	0.06%	380
2021 Q1	$6.43M	Sell	11,251 -35	-0.3%	-$20.7K	0.04%	526
2020 Q4	$6.58M	Buy	11,286 +8,830	+360%	+$5.03M	0.04%	471
2020 Q3	$1.27M	Sell	2,456 -778	-24%	-$394K	0.01%	1104
2020 Q2	$1.46M	Buy	3,234 +2,465	+321%	+$1.09M	0.01%	1023
2020 Q1	$270K	Sell	769 -1,157	-60%	-$425K	﹤0.01%	1564
2019 Q4	$713K	Sell	1,926 -13,736	-88%	-$4.84M	0.01%	1472
2019 Q3	$5.21M	Buy	15,662 +6,230	+66%	+$2.03M	0.04%	578
2019 Q2	$2.95M	Buy	9,432 +169	+2%	+$50.6K	0.02%	875
2019 Q1	$2.83M	Sell	9,263 -1,253	-12%	-$338K	0.02%	915
2018 Q4	$2.44M	Sell	10,516 -12,129	-54%	-$3.25M	0.02%	935
2018 Q3	$7.09M	Buy	22,645 +3,554	+19%	+$1.1M	0.05%	515
2018 Q2	$5.51M	Sell	19,091 -16,889	-47%	-$4.66M	0.04%	655
2018 Q1	$9M	Sell	35,980 -999	-3%	-$254K	0.02%	719
2017 Q4	$8.83M	Buy	36,979 +8,236	+29%	+$2M	0.02%	734
2017 Q3	$6.39M	Buy	28,743 +2,264	+9%	+$509K	0.02%	914
2017 Q2	$5.99M	Sell	26,479 -224	-0.8%	-$48.8K	0.02%	917
2017 Q1	$5.32M	Buy	26,703 +103	+0.4%	+$19.8K	0.01%	982
2016 Q4	$4.85M	Sell	26,600 -5,535	-17%	-$944K	0.01%	1026
2016 Q3	$5.26M	Sell	32,135 -4,459	-12%	-$677K	0.02%	989
2016 Q2	$5.23M	Sell	36,594 -2,080	-5%	-$297K	0.02%	966
2016 Q1	$5.29M	Sell	38,674 -14,139	-27%	-$1.86M	0.02%	960
2015 Q4	$7.32M	Sell	52,813 -15,044	-22%	-$2.09M	0.02%	869
2015 Q3	$9.11M	Sell	67,857 -6,851	-9%	-$986K	0.03%	792
2015 Q2	$11.3M	Buy	74,708 +9,408	+14%	+$1.35M	0.03%	785
2015 Q1	$8.83M	Buy	65,300 +12,805	+24%	+$1.59M	0.02%	910
2014 Q4	$6.33M	Buy	52,495 +6,279	+14%	+$723K	0.02%	1024
2014 Q3	$5.24M	Buy	46,216 +2,621	+6%	+$311K	0.01%	1174
2014 Q2	$5.22M	Sell	43,595 -12,354	-22%	-$1.51M	0.01%	1161
2014 Q1	$7.17M	Buy	55,949 +6,755	+14%	+$866K	0.02%	965
2013 Q4	$6.08M	Sell	49,194 -6,887	-12%	-$839K	0.02%	1004
2013 Q3	$6.59M	Buy	56,081 +13,734	+32%	+$1.62M	0.02%	970
2013 Q2	$4.75M	Buy	+42,347	New	+$4.97M	0.02%	1074